helena colom

Associate professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Drug Delivery Drug Delivery professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Helena Colom is an Associate Professor at the University of Barcelona, Spain. Her research focuses on pharmacokinetic modeling and drug dosage optimization, with recent articles addressing renal function formulas for drug individualization in transplant patients, as well as the pharmacokinetics of anti-inflammatory drugs. She is also involved in studies related to the clinical response of infliximab in psoriasis and the delivery mechanisms for treating local inflammation.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Òscar Domènech

Associate Professor

University of Barcelona

SPAIN

View details

María J. Rodríguez-Lagunas

SPAIN

View details

Beatriz Clares-Naveros

Universidad de Granada

SPAIN

View details

Jordi Carratalà

Bellvitge University Hospital

SPAIN

View details

J. Bruno Montoro-Ronsano

Profesor Asociado

University of Barcelona

SPAIN

View details

jose m lizcano

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

helena colom

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Population Pharmacokinetic modeling of fibrinogen in patients with congenital or acquired ‐chronic or acute‐ hypofibrinogenemia.

Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome

Enhanced transdermal delivery of pranoprofen using a thermo-reversible hydrogel loaded with lipid nanocarriers for the treatment of local inflammation

Swine as the Animal Model for Testing New Formulations of Anti-Inflammatory Drugs: Carprofen Pharmacokinetics and Bioavailability of the Intramuscular Route

A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.

Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study

Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy

Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

Collaborators (6)

Òscar Domènech

María J. Rodríguez-Lagunas

Beatriz Clares-Naveros

Jordi Carratalà

J. Bruno Montoro-Ronsano

jose m lizcano

Make your next move.